Inhibition of ITK differentiates GVT and GVHD in allo-HSCT
Preprint
Abstract
Allogeneic hematopoietic stem cell transplantation is a life-saving treatment for many malignant and nonmalignant diseases. Donor T cells contained within the graft prevent tumor recurrence via graft-versus-tumor (GVT) effects, however, also cause graft-versus-host disease (GVHD). Novel treatment strategies are therefore needed to allow maintenance of GVT while suppressing GVHD. Here we show using murine models, that targeting IL-2-inducible T cell kinase (ITK) in donor T cells reduces GVHD while preserving the beneficial GVT effects. Donor T cells from Itk -/- mice exhibit significantly reduced production of inflammatory cytokines and migration to GVHD target organs such as liver and small intestine, while maintaining GVT efficacy against primary B-ALL tumors. Itk -/- T cells exhibited reduced expression of IRF4 and decreased JAK/STAT signaling activity, but preserved cytotoxicity, which was accompanied by upregulation of Eomesodermin (Eomes), which was necessary for GVT function. A novel peptide inhibitor ITK signaling is also able to prevent GVHD. This novel peptide inhibitor also reduced cytokine production in mice and human T cells. Altogether, our data suggest that inhibiting ITK could be a therapeutic strategy to reduce GVHD while preserving the beneficial GVT effects following allo-HSCT treatment. Key Points: Inhibiting ITK by a novel peptide significantly reduces GVHD but retains GVT. ITK deficient donor T cells exhibit minimal GVHD, but maintain GVT activity. ITK deficient donor T cells exhibit significantly reduced production of inflammatory cytokines and migration to GVHD target organs. Eomes is required for GVT effect.Keywords
This publication has 81 references indexed in Scilit:
- Cutting Edge: Innate Memory CD8+ T Cells Are Distinct from Homeostatic Expanded CD8+ T Cells and Rapidly Respond to Primary Antigenic StimuliThe Journal of Immunology, 2013
- Molecular Characteristics of CTA056, a Novel Interleukin-2-Inducible T-Cell Kinase Inhibitor that Selectively Targets Malignant T Cells and Modulates OncomirsMolecular Pharmacology, 2012
- Augmentation of anti-tumor immunity by adoptive T-cell transfer after allogeneic hematopoietic stem cell transplantationExpert Review of Hematology, 2012
- Dual regulation of IRF4 function in T and B cells is required for the coordination of T–B cell interactions and the prevention of autoimmunityJournal of Experimental Medicine, 2012
- T-cell receptor signals direct the composition and function of the memory CD8+ T-cell poolBlood, 2010
- Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in miceJournal of Clinical Investigation, 2010
- T cells expressing the transcription factor PLZF regulate the development of memory-like CD8+ T cellsNature Immunology, 2010
- Complementation In Trans of Altered Thymocyte Development in Mice Expressing Mutant Forms of the Adaptor Molecule SLP76Immunity, 2008
- Memory phenotype CD8+ T cells with innate function selectively develop in the absence of active ItkEuropean Journal of Immunology, 2007
- Basic Local Alignment Search ToolJournal of Molecular Biology, 1990